Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
3 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
Jul 14, 2025, 18:25

3 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke

Stroke AHA/ASA Journal posted on X:

”In the secondary analysis of the ANGEL-REBOOT trial, longer puncture-to-recanalization time was associated with an increased risk of early reocclusion, while general anesthesia and eTICI 2c-3 were associated with a reduced risk of early reocclusion.”

Read the full article here.

ANGEL-REBOOT trial yields important clinical facts!

The findings were published in the research article ”Factors Associated With Early Reocclusion in Recanalized Intracranial Atherosclerotic Occlusion: ANGEL-REBOOT Insights” in Stroke, with following conclusions:

  • In patients with intracranial atherosclerotic occlusion (ICAS-O) stroke, early reocclusion after successful mechanical thrombectomy is linked to poor outcomes.
  • A post hoc analysis from a multicenter trial identified that longer puncture-to-recanalization time increases the risk of early reocclusion within 24 hours.
  • Conversely, general anesthesia and achieving a postprocedural eTICI score of 2c-3 were associated with a lower risk.

These findings offer valuable insights for optimizing procedural strategies to improve outcomes in ICAS-O stroke.

3 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke

Hemostasis Today, your daily update on the latest scientific advancements on the field of stroke management.

American Stroke Association ANGEL-REBOOT trial Health Hematology Hemostasis Today ICAS-O Stroke intracranial atherosclerotic occlusion Medicine Stroke AHA/ASA
NewsFeed